Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2006-06-30 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-LAURENT-DU-MARONI (97320), Guyane
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE NOUVELLE DE LA MAIRIE : revenue, balance sheet and financial ratios
PHARMACIE NOUVELLE DE LA MAIRIE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-LAURENT-DU-MARONI (97320),
this company of category PME
shows in 2024 a net income positive of 94 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NOUVELLE DE LA MAIRIE (SIREN 491378675)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
93 632 €
192 168 €
130 919 €
145 732 €
133 236 €
70 828 €
74 771 €
18 321 €
88 656 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE NOUVELLE DE LA MAIRIE generates positive net income of 94 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 89 k€ -> 94 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
93 632 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 35%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
34.575%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.201%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE NOUVELLE DE LA MAIRIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
65.905
71.523
54.48
38.098
52.7
35.204
25.995
22.478
34.575
Financial autonomy
32.453
33.363
37.094
38.275
41.502
48.582
51.492
55.862
54.201
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
34.582024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good+10 pts over 3 years
In 2024, the debt ratio of PHARMACIE NOUVELLE DE LA ... (34.58) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
54.2%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE NOUVELLE DE LA ... (54.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 104.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
104.505
Liquidity indicators evolution PHARMACIE NOUVELLE DE LA MAIRIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
43.88
38.215
46.097
56.933
101.095
107.988
108.927
122.158
104.505
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
104.52024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of PHARMACIE NOUVELLE DE LA ... (104.50) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE NOUVELLE DE LA MAIRIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE NOUVELLE DE LA MAIRIE is estimated at
1 307 171 €
(range 910 293€ - 1 955 604€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
910k€1307k€1955k€
1 307 171 €Range: 910 293€ - 1 955 604€
NAF 5 année 2024
Valuation method used
Net Income Multiple
93 632 €
×
14.0x
=1 307 172 €
Range: 910 294€ - 1 955 604€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NOUVELLE DE LA MAIRIE with other companies in the same sector:
Frequently asked questions about PHARMACIE NOUVELLE DE LA MAIRIE
What is the revenue of PHARMACIE NOUVELLE DE LA MAIRIE ?
The revenue of PHARMACIE NOUVELLE DE LA MAIRIE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE NOUVELLE DE LA MAIRIE profitable?
Yes, PHARMACIE NOUVELLE DE LA MAIRIE generated a net profit of 94 k€ in 2024.
Where is the headquarters of PHARMACIE NOUVELLE DE LA MAIRIE ?
The headquarters of PHARMACIE NOUVELLE DE LA MAIRIE is located in SAINT-LAURENT-DU-MARONI (97320), in the department Guyane.
Where to find the tax return of PHARMACIE NOUVELLE DE LA MAIRIE ?
The tax return of PHARMACIE NOUVELLE DE LA MAIRIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NOUVELLE DE LA MAIRIE operate?
PHARMACIE NOUVELLE DE LA MAIRIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart